Spark Therapeutics Announces 15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy … – EconoTimes
|
Spark Therapeutics Announces 15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy …
EconoTimes PHILADELPHIA, Jan. 04, 2017 — Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that it has earned a $15 million payment from Pfizer Inc. Spark Therapeutics to Participate in J.P. Morgan Healthcare Conference |
